Related Experiment Video
Updated: Apr 26, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy
Judith A Groeneweg1, Amber Ummels2, Marcel Mulder2
1Department of Cardiology, University Medical Center Utrecht and ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.
Insights
Functional analysis of splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) genes identified six pathogenic mutations. This research clarifies genetic variants, improving ARVD/C diagnosis and patient care.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Disease Mechanisms
Background:
- Interpreting genetic screening results for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is challenging.
- Software algorithms predict variant pathogenicity, but functional assessment provides definitive evidence.
- This study focuses on variants of uncertain clinical significance in ARVD/C.
Purpose of the Study:
- To conduct functional analysis of potential splice site variants in patients diagnosed with or suspected of having ARVD/C.
- To determine the impact of specific genetic variants on RNA splicing.
- To clarify the pathogenicity of uncertain variants in ARVD/C.
Main Methods:
- Analyzed nine potential splice site variants in desmosomal genes (PKP2, JUP, DSG2, DSC2) from ARVD/C patients.
- RNA was isolated from blood samples and analyzed using reverse transcriptase polymerase chain reaction (RT-PCR).
- Assessed the effect of variants on mRNA splicing, including exon skipping and altered splice site usage.
Main Results:
- Software predicted splicing effects for all nine variants.
- Functional analysis confirmed deleterious splicing effects in six of the nine variants.
- Five intronic variants severely impaired splicing, while only one of four exonic variants showed a significant effect.
Conclusions:
- Six variants in PKP2, JUP, and DSG2 genes demonstrated a pathogenic effect on mRNA splicing, confirming them as ARVD/C-related mutations.
- Functional assessment is crucial for accurately interpreting potential splice site variants.
- These findings enhance patient care and facilitate cascade screening for ARVD/C.
Background:
Interpretation of genetic screening results in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) often is difficult. Pathogenicity of variants with uncertain clinical significance may be predicted by software algorithms. However, functional assessment can unambiguously demonstrate the effect of such variants.
Objective:
The purpose of this study was to perform functional analysis of potential splice site variants in ARVD/C patients.
Methods:
Nine variants in desmosomal (PKP2, JUP, DSG2, DSC2) genes with potential RNA splicing effect were analyzed. The variants were found in patients who fulfilled 2010 ARVD/C Task Force Criteria (n = 7) or had suspected ARVD/C (n = 2). Total RNA was isolated from fresh blood samples and subjected to reverse transcriptase polymerase chain reaction.
Results:
An effect on splicing was predicted by software algorithms for all variants. Of the 9 variants, 5 were intronic and 4 exonic. RNA analysis showed a functional effect on mRNA splicing by exon skipping, generation of new splice sites, or activation of cryptic sites in 6 variants. All 5 intronic variants tested severely impaired splicing. Only 1 of 4 exonic potential splice site variants was shown to have a deleterious effect on splicing. The remaining 3 exonic variants had no detectable effect on splicing, and heterozygous presence in mRNA confirmed biallelic expression.
Conclusion:
Six variants of uncertain clinical significance in the PKP2, JUP, and DSG2 genes showed a deleterious effect on mRNA splicing, indicating these are ARVD/C-related pathogenic splice site mutations. These results highlight the importance of functional assessment of potential splice site variants to improve patient care and facilitate cascade screening.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

